CLINICAL_TRIALS
trial_result
· 2019-01-03
Clinical Trial Update: TAK-438 Bismuth Drug Interaction Study [Phase 1]
Summary
Phase 1 study update on TAK-438 bismuth drug interaction in Helicobacter pylori infection; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Helicobacter Pylori | Phase 1 | Status: COMPLETED | Results posted: 2019-01-03